Eureka Therapeutics, Inc. — Form D

Eureka Therapeutics, Inc. of Emeryville, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-18. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Wiliam S Solari IIIDirectorEmeryville, CA
Lewis T WilliamsDirectorSouth San Francisco, CA
Christopher T LehmanExecutive OfficerEmeryville, CA
Bijan T NejadnikExecutive OfficerEmeryville, CA
Victor T ShumExecutive OfficerHackensack, NJ
Reed JobsDirectorSan Francisco, CA
Vivien S ChanExecutive OfficerEmeryville, CA
Cheng LiuDirectorEmeryville, CA
Cheng LiuExecutive OfficerEmeryville, CA
Michael CannonDirectorEmeryville, CA
Marvin SamsonDirectorEmeryville, CA
William S Solari IIIDirectorEmeryville, CA
"Wai-Yan ""Sandy""" ChauDirectorEmeryville, CA
Victor S ShumExecutive OfficerEmeryville, CA
Jacqueline NorthcutDirectorEmeryville, CA
"Chih-Kai ""C.K." ChengDirectorEmeryville, CA
Chih-Kai ChengDirectorSanta Clara, CA
Jacqueline S NorthcutDirectorEmeryville, CA
Marvin T SamsonDirectorEmeryville, CA
Michael D CannonDirectorEmeryville, CA
"Wai-Yan ""Sandy""" D ChauDirectorEmeryville, CA
"Chih-Kai ""C.K.""" D ChengDirectorEmeryville, CA
Bo D FengDirectorEmeryville, CA
Sandy ChauDirectorEmeryville, CA
Hsing KungDirectorEmeryville, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2023-05-17D$20.0M
2020-01-24D$45.0M$45.0M
2017-05-30D/A$60.0M$26.6M
2016-12-12D$40.0M
2014-09-22D$21.0M$21.0M

More